Table 30.

Occurrence of resistance to selected antimicrobials in indicator E. coli from fattening pigs in reporting MSs in 2015, using harmonised ECOFFs

Country	Ampicillin		Azithromycin		Cefotaxime		Ceftazidime		Chloramphenicol		Ciprofloxacin		Colistina
	N	% Res	N	% Res	N	% Res	N	% Res	N	% Res	N	% Res	N	% Res
2015
Austria	163	12.9	163	0	163	2.5	163	1.8	163	3.7	163	4.9	163	0.6
Belgium	186	35.5	186	0	186	1.1	186	1.1	186	17.7	186	2.2	186	0
Bulgaria	21	57.1	21	4.8	21	0	21	0	21	52.4	21	47.6	21	0
Croatia	85	32.9	85	0	85	0	85	0	85	10.6	85	7.1	85	0
Cyprus	55	89.1	55	45.5	55	5.5	55	5.5	55	69.1	55	43.6	55	0
Czech Republic	187	34.8	187	1.1	187	2.1	187	2.6	187	8.6	187	2.1	187	0
Denmark	174	31.6	174	0.6	174	0	174	0	174	2.3	174	1.1	174	0.6
Estonia	85	31.8	85	1.2	85	1.2	85	1.2	85	9.4	85	7.1	85	0
Finland	217	14.3	217	0	217	0	217	0	217	0.9	217	0.5	217	0
France	200	19.5	200	0.5	200	0.5	200	0.5	200	12	200	4.5	200	0
Germany	212	33	212	2.4	212	3.3	212	3.3	212	6.6	212	4.2	212	0
Greece	116	57.8	116	2.6	116	5.2	116	5.2	116	36.2	116	12.1	116	0
Hungary	170	39.4	170	0.6	170	1.2	170	1.2	170	11.2	170	8.2	170	0
Ireland	147	25.2	147	1.4	147	0.7	147	0.7	147	10.2	147	2.7	147	0
Italy	168	63.7	168	1.8	168	0.6	168	0	168	32.7	168	14.9	168	0.6
Latvia	150	26.7	150	0	150	0	150	0	150	8	150	5.3	150	0.7
Lithuania	89	34.8	89	2.2	89	0	89	0	89	11.2	89	10.1	89	2.2
Malta	68	25	68	0	68	0	68	0	68	10.3	68	5.9	68	0
Netherlands	298	28.9	298	1	298	0.3	298	0.3	298	9.4	298	0.7	298	0
Poland	170	35.9	170	0	170	4.1	170	4.7	170	12.4	170	15.9	170	0
Portugal	198	74.7	198	14.6	198	5.1	198	5.1	198	52	198	20.7	198	2.5
Romania	399	67.2	399	7.8	399	1.5	399	1.5	399	40.9	399	29.6	399	0.5
Slovakia	85	31.8	85	1.2	85	0	85	0	85	15.3	85	7.1	85	0
Slovenia	85	22.4	85	1.2	85	0	85	0	85	7.1	85	2.4	85	0
Spain	170	82.4	170	2.9	170	0.6	170	0.6	170	40	170	49.4	170	2.9
Sweden	200	20.5	200	0.5	200	1	200	0	200	3	200	2.5	200	0
United Kingdom	170	35.3	170	1.2	170	0	170	0	170	28.2	170	2.4	170	0.6
Total (27 MSs)	4,268	39.3	4,268	2.8	4,268	1.4	4,268	1.3	4,268	18.3	4,268	10.5	4,268	0.4
Norway	270	11.1	270	0	270	0.7	270	0.4	270	2.2	270	0.7	270	0
Switzerland	182	17.0	182	0	182	0.5	182	0.5	182	8.2	182	3.3	182	0
2014
Denmark	82	36.6	82	0	82	0	82	0	82	2.4	82	1.2	82	0
Netherlands	392	24.0	392	0	392	0.5	392	1.0	392	12.0	392	0	392	0
Total (2 MSs)	474	26.2	474	0	474	0.4	474	0.8	474	10.3	474	0.2	474	0

Country	Gentamicin		Nalidixic acid		Sulfamethoxazole		Tetracycline		Tigecyclineb		Trimethoprim
	N	% Res	N	% Res	N	% Res	N	% Res	N	% Res	N	% Res
2015
Austria	163	2.5	163	3.1	163	22.7	163	47.2	163	0	163	10.4
Belgium	186	1.6	186	1.6	186	43.0	186	40.3	186	0	186	38.2
Bulgaria	21	0	21	23.8	21	90.5	21	76.2	21	0	21	28.6
Croatia	85	3.5	85	10.6	85	40.0	85	56.5	85	0	85	21.2
Cyprus	55	21.8	55	21.8	55	98.2	55	100	55	14.5	55	94.5
Czech Republic	187	3.2	187	1.1	187	36.9	187	48.1	187	0	187	25.1
Denmark	174	1.1	174	0.6	174	35.6	174	35.6	174	0	174	24.1
Estonia	85	1.2	85	4.7	85	34.1	85	41.2	85	0	85	25.9
Finland	217	0.9	217	0.5	217	17.1	217	21.2	217	0	217	15.2
France	200	2.0	200	4.5	200	41.0	200	54.5	200	0	200	34.5
Germany	212	3.3	212	2.4	212	35.4	212	44.8	212	0	212	25.9
Greece	116	3.4	116	8.6	116	64.7	116	79.3	116	0	116	56.9
Hungary	170	2.4	170	6.5	170	30.0	170	68.2	170	0	170	17.1
Ireland	147	2.0	147	2.0	147	44.2	147	59.2	147	0	147	36.7
Italy	168	4.2	168	6.5	168	63.1	168	72.0	168	0	168	58.3
Latvia	150	4.0	150	4.0	150	29.3	150	44.0	150	0	150	20.7
Lithuania	89	3.4	89	7.9	89	43.8	89	51.7	89	0	89	29.2
Malta	68	4.4	68	4.4	68	42.6	68	69.1	68	1.5	68	41.2
Netherlands	298	0.7	298	0.7	298	40.3	298	45.3	298	0	298	35.9
Poland	170	1.8	170	6.5	170	36.5	170	48.2	170	0	170	18.8
Portugal	198	2.0	198	9.1	198	76.8	198	89.4	198	0	198	68.7
Romania	399	9.0	399	16.0	399	63.4	399	74.2	399	0	399	47.6
Slovakia	85	3.5	85	7.1	85	34.1	85	48.2	85	0	85	22.4
Slovenia	85	0	85	0	85	15.3	85	40.0	85	0	85	14.1
Spain	170	3.5	170	25.9	170	75.9	170	89.4	170	0	170	74.7
Sweden	200	0.5	200	2.0	200	25.0	200	10.0	200	0	200	19.5
United Kingdom	170	7.6	170	1.2	170	54.7	170	67.6	170	0	170	47.1
Total (27 MSs)	4,268	3.3	4,268	6.0	4,268	44.2	4,268	54.7	4,268	0.2	4,268	35.3
Norway	270	0	270	0.7	270	14.1	270	9.6	270	1.1	270	9.6
Switzerland	182	1.6	182	3.3	182	41.8	182	29.7	182	0	182	22.0
2014
Denmark	82	1.2	82	1.2	82	35.4	82	41.5	82	0	82	31.7
Netherlands	392	3.6	392	0.3	392	41.3	392	49.2	392	0	392	30.9
Total (2 MSs)	474	3.2	474	0.4	474	40.3	474	47.9	474	0	474	31

All E. coli isolates tested were susceptible to meropenem. MSs: Member States; N: number of isolates tested; % Res: percentage of resistant isolates.

^aThe reported occurrence of colistin resistance is unlikely to equate to the occurrence of mcr‐1/mcr‐2 genes.

^bECOFF applied 1 mg/L.